Convex Finance price prediction October 2026

CVXRank #161DeFiUpdated 25 Oct 2026, 15:30 UTC · Reviewed by Rowan Hale

Our model expects Convex Finance to trade between $1.60 and $3.68 by 22 November 2026, with a base case of $2.33 (-4.3%).

Price$2.43▲ 3.7% 24h
7 days+29.8%from $1.87
24h volume$10.42M4.6% of cap
Market cap$226.56MRank #161
All-time high$60.09-96.0% from ATH
Circulating93.19Mof 100M max
Market data by CoinGecko. Forecasts by the CoinPredict model.

AI verdict

model 1d-20261023-1104 · made 23 Oct 2026, 00:00 UTC
30-day directionNeutral
Confidence—
Risk score48 / 100 · Moderate
Volatility, liquidity, cap tier, drawdown
30-day base case$2.33 -4.3%
80% range$1.60 – $3.68
Expires22 Nov 2026

Price and 30-day forecast

21 Oct21 Oct22 OctToday22 Nov
PriceBase case50% and 80% ranges

Forecast by horizon

Low and high are the 10th and 90th percentiles
HorizonLowBaseHighChangeConfidenceExpires
24 hours$2.29$2.45$2.61+0.7%—24 Oct 2026
7 days$2.03$2.42$2.92-0.3%—30 Oct 2026
30 days$1.60$2.33$3.68-4.3%—22 Nov 2026
90 days$1.11$2.12$4.88-12.9%—21 Jan 2027
180 days$0.786$1.89$5.99-22.2%—21 Apr 2027

Long-term scenarios, 2026 to 2030

Scenarios, not forecasts

Built from Convex Finance's past cycle drawdowns and the growth of its market-cap tier. Each row links to a month-by-month page.

Year-endBearBaseBullBase vs today
2026$1.34$2.34$4.08-3.8%2026 →
2027$0.446$1.82$7.43-25.1%2027 →
2028$0.210$1.42$9.58-41.7%2028 →
2029$0.110$1.10$11.08-54.6%2029 →
2030$0.0612$0.860$12.09-64.6%2030 →

Technicals

RSI (14, daily)61 · Neutral
MACDBullish cross, 2 days ago
50-day average$2.12 · price above
200-day average$1.70 · price above
Resistance 1$2.50
Support 1$2.40
Support 2$2.17

How our Convex Finance calls did

Full track record →
24-hour calls in range50%of 2 graded
Direction correct100%of 2 graded
Median miss3.9%base vs actual

Where do you think Convex Finance goes this month?

Votes are unavailable right now.

Not financial advice.Forecasts are model estimates, not guarantees. Crypto is volatile — do your own research.Read the disclaimer